Expanded Real-World Data Presented at INS 2025 Reinforces Better Outcomes with Access Vascular's Hydrophilic Midline Catheter

Associated Press

29-04-2025

BILLERICA, Mass.--(BUSINESS WIRE)--Apr 29, 2025--
Access Vascular, Inc. (AVI), a leader in advanced vascular access technology, today announced the presentation of new, expanded real-world data at the 2025 Infusion Nurses Society (INS) Annual Meeting in Las Vegas. The data reinforces significant improvements in midline catheter outcomes associated with AVI's proprietary hydrophilic biomaterial (HBM), building on findings previously shared at the Association for Vascular Access Annual Meeting in 2024.
The study was independently designed and conducted by an acute care hospital in Montana and evaluated outcomes across 288 patients. It compared a conventional chlorhexidine gluconate (CHG)-coated polyurethane catheter to Access Vascular's HydroMID® HBM-based catheter.
Key findings announced at INS 2025:
'With more than 125 catheters in each study arm, these findings add to the growing body of evidence that our hydrophilic biomaterial platform delivers tangible benefits where it matters most: improved outcomes for patients,' said Jim Biggins, CEO of Access Vascular. 'Fewer complications, longer dwell times, and higher rates of therapy completion all support a safer, more efficient experience for patients and providers alike.'
Unlike traditional polyurethane catheters, AVI's devices are constructed from MIMIX®, a proprietary hydrogel-based material designed to reduce thrombus formation and bacterial adhesion. This fundamental material change targets the root causes of vascular access device failure.
'Concerns relating to frequent complications with our previous midline device kept growing. We felt defeated in our efforts to get our patients to the end of their therapy – we knew we could do better for them,' said Kelsey Pearson, RN, VA-BC at Benefis Hospital. 'We have noticed a significant improvement in our outcomes and provided a better patient experience since switching to the HydroMID® catheter.'
About Access Vascular
Access Vascular, Inc. (AVI) is redefining vascular access by engineering devices from a fundamentally better material. The MIMIX® hydrogel platform is designed to reduce the complications associated with traditional catheters, helping clinicians keep lines in place, improving the patient experience and delivering value to hospitals. For more information, please visit www.accessvascularinc.com, and follow us on LinkedIn.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250429883734/en/
CONTACT: Media Contact:
Brad Perriello
Circle Hill Communications
[email protected]
617.817.1385
KEYWORD: UNITED STATES NORTH AMERICA NEVADA MASSACHUSETTS
INDUSTRY KEYWORD: NURSING MEDICAL SUPPLIES HEALTH MEDICAL DEVICES HOSPITALS HEALTH TECHNOLOGY CARDIOLOGY
SOURCE: Access Vascular, Inc.
Copyright Business Wire 2025.
PUB: 04/29/2025 07:06 AM/DISC: 04/29/2025 07:06 AM
http://www.businesswire.com/news/home/20250429883734/en